FASS logotyp

Peka på symbolerna och beteckningarna till vänster för en förklaring.


Sök apotek med läkemedlet i lager

Sök lagerstatus



Ögondroppar, lösning 3 mg/ml
(Klar, färglös till blekgul lösning)

Kemoterapeutikum av kinolontyp

Aktiv substans:
ATC-kod: S01AE03
Utbytbarhet: Ej utbytbar
Läkemedel från Novartis omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?




Miljörisk: Användning av ciprofloxacin har bedömts medföra hög risk för miljöpåverkan.
Nedbrytning: Ciprofloxacin är potentiellt persistent.
Bioackumulering: Ciprofloxacin har låg potential att bioackumuleras.

Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (μg/L) = (A*109*(100-R)) / (365*P*V*D*100)= 0.43 μg/L

PEC = 0.43 μg/L


A = 2866.28 kg Ciprofloxacin (total amount of all four salts of Ciprofloxacin sold in Sweden in 2019, data from IQVIA).

R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available.

P = number of inhabitants in Sweden = 9 ×106 

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (ECHA 2008)

D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (ECHA 2008)

Predicted No Effect Concentration (PNEC)

Ecotoxicological studies

Cyanobacteria / blue-green algae (Mycrocystis aeruginosa) (OECD 201) (Halling-Sørensen, 2000):

EC50 (endpoint not specified) = 0.005 mg/L

Green algae:

Selenastrum capricornutum (OECD 201) (Halling-Sørensen, 2000):

EC50 (endpoint not specified) = 2.97 mg/L

Pseudokirchneriella subcapitata (OECD 201) (Martins, 2012)

EC50 96 h (growth inhibition) = 4.83 mg/L

Crustacean (Daphnia magna, giant waterflea):

Acute toxicity

EC50 48 h (immobilization) = 65.3 mg/L (OECD 202) (Martins, 2012)

Chronic toxicity

NOEC 21 days (size of neonates from first brood) = 1.8 mg/L (OECD 202 Part II) (Martins, 2012)

NOEC 28 days (reproduction) = 0.156 mg/L (OECD 211) (Zaleska-Radziwill, 2011)


Acute toxicity (Gambusia holbrooki, Eastern mosquitofish)

LC50 96 h (lethality) > 60.0 mg/L (OECD 203) (Martins, 2012)

Chronic toxicity (Lebistes reticulatus, guppy)

NOEC 28 days (juvenile growth stimulation) = 0.78 mg/L (OECD 215) (Zaleska-Radziwill, 2011)

Other ecotoxicity data:

Bacterial respiration inhibition

EC50 = 0.61 mg/L (activated sludge respiration inhibition) (ISO 15522) (Halling-Sørensen, 2000)

PNEC derivation:

PNEC = 5.0 ng/L

The PNEC is based on the lowest EC50 / 1000, where 1000 is the assessment factor used if acute data for 3 trophic levels is available. The EC50 for growth inhibition in the cyanobacteria Mycrocystis aeruginosa has been used for this calculation since it is the most sensitive of the three tested species.

Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 0.43 μg/L / 0.005 μg/L = 86, i.e. PEC/PNEC > 10, which justifies the phrase “Use of ciprofloxacin has been considered to result in high environmental risk.”


Biotic degradation

Ready degradability:

Not readily degradable (28 days; Measurement of biological oxygen demand according to the guidelines published by OECD). (Halling-Sørensen, 2000)

Justification of chosen degradation phrase:

Ciprofloxacin is not readily biodegradable. Therefore, the phrase 'Ciprofloxacin is potentially persistent' is chosen.


Partitioning coefficient:

Log Kow = 1.24 (estimated with ACD Log P software (Advanced Chemical Development, Toronto, Canada) (Halling-Sørensen, 2000)

Justification of chosen bioaccumulation phrase:

Since log Kow < 4, ciprofloxacin has a low potential for bioaccumulation.

Excretion (metabolism

Ciprofloxacin is eliminated by renal and non-renal mechanisms. The drug is partially metabolized in the liver by modification of the piperazinyl group to at least 4 metabolites. These metabolites, which have been identified as desethyleneciprofloxacin (M1), sulfociprofloxacin (M2), oxociprofloxacin (M3), and N-formylciprofloxacin (M4), have a microbiologic activity that is less than that of the parent drug.

Ciprofloxacin and its metabolites are excreted in urine and feces. Unchanged ciprofloxacin is excreted in urine by both glomerular filtration and tubular secretion. Following oral administration of a single 250-, 500-, or 750-mg dose in adults with normal renal function, 15–50% of the dose is excreted in urine as unchanged drug and 10–15% as metabolites within 24 hours; 20–40% of the dose is excreted in feces as unchanged drug and metabolites within 5 days. Most, but not all, of unchanged ciprofloxacin in feces appears to result from biliary excretion. (Medicines Complete 2017).

PBT/vPvB assessment

The substance does not fulfill the Toxic (T) criteria given that the chronic NOEC > 0.01 mg/L. PBT/vPvB assessment is not possible due to lack of complete data.


  • ECHA 2008, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm

    B. Halling-Sørensen, H.-C. Holten Lützhøft, H.R. Andersen, and F. Ingerslev. 2000. Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim, and ciprofloxacin. Journal of Antimicrobial Chemotherapy 46, Suppl. S1, 53-58

  • N. Martins, R. Pereira, N. Abrantes, J. Pereira, F. Gonçalves, C. R. Marques. 2012. Ecotoxicological effects of ciprofloxacin on freshwater species: data integration and derivation of toxicity thresholds for risk assessment. Ecotoxicology 21, 1167-1176.

  • M. Zaleska-Radziwill, M. Lebkowska, K. Affek, A. Zarzeczna. 2011. Environmental risk assessment of selected pharmaceuticals present in surface waters in relation to animals. Archives of Environmental Protection 37 (3), 31-42.

  • MedicinesComplete © 2017 Royal Pharmaceutical Society. AHFS Drug Information. https://www.medicinescomplete.com/mc/ahfs/current/a388016.htm?q=ciprofloxacin&t=search&ss=text&tot=117&p=2#_hit